Medpace Holdings, Inc.
MEDP
$332.81
$7.082.17%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 7.66% | 8.29% | 14.59% | 17.73% | 26.47% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.66% | 8.29% | 14.59% | 17.73% | 26.47% |
| Cost of Revenue | 1.97% | 4.37% | 8.21% | 13.52% | 16.78% |
| Gross Profit | 10.46% | 10.25% | 17.93% | 19.98% | 31.85% |
| SG&A Expenses | 6.87% | 18.86% | 5.20% | 15.92% | 27.28% |
| Depreciation & Amortization | 7.66% | 9.31% | 10.97% | 17.35% | 18.19% |
| Other Operating Expenses | -3.32% | -1.11% | 13.87% | 20.67% | 43.31% |
| Total Operating Expenses | 0.03% | 3.30% | 10.58% | 16.99% | 29.41% |
| Operating Income | 43.58% | 32.23% | 34.13% | 20.72% | 14.25% |
| Income Before Tax | 47.60% | 42.76% | 45.86% | 31.10% | 23.17% |
| Income Tax Expenses | 35.90% | 76.67% | 50.80% | -22.42% | 149.43% |
| Earnings from Continuing Operations | 49.45% | 36.68% | 44.68% | 40.74% | 14.02% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 49.45% | 36.68% | 44.68% | 40.74% | 14.02% |
| EBIT | 43.58% | 32.23% | 34.13% | 20.72% | 14.25% |
| EBITDA | 40.93% | 30.51% | 32.35% | 20.51% | 14.53% |
| EPS Basic | 48.46% | 34.93% | 42.66% | 41.53% | 15.77% |
| Normalized Basic EPS | 46.52% | 40.84% | 43.73% | 31.80% | 25.07% |
| EPS Diluted | 49.22% | 35.59% | 42.49% | 40.97% | 16.52% |
| Normalized Diluted EPS | 47.37% | 41.31% | 43.54% | 31.72% | 25.49% |
| Average Basic Shares Outstanding | 0.74% | 1.36% | 1.48% | -0.53% | -1.52% |
| Average Diluted Shares Outstanding | 0.15% | 1.03% | 1.62% | -0.48% | -1.84% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
